Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2016 August;64(4) > Minerva Cardioangiologica 2016 August;64(4):473-80

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  NEW BIORESORBABLE TECHNOLOGY IN INTERVENTIONAL CARDIOLOGY


Minerva Cardioangiologica 2016 August;64(4):473-80

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Overview of the clinical trials on bioresorbable vascular scaffold

Angela FERRARA 1, Giuseppe DI GIOIA 2, Teresa STRISCIUGLIO 2, William WIJNS 1, Emanuele BARBATO 1, 2

1 Cardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium; 2 Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy


PDF  


Although several new scaffolds are progressively being investigated and entering the clinical scene, BRS has accumulated the largest experience by far including detailed evaluation of the first patients studied followed almost in parallel by clinical evaluation and worldwide randomized evaluation for non-inferiority against best contemporary metallic DES. Available evidence shows that careful procedural technique is required for proper and safe delivery of the current generation scaffolds. Future studies will indicate whether all or only selected patient or lesion subsets will ultimately benefit from treatment with fully bioresorbable devices.

top of page

Publication History

Cite this article as

Corresponding author e-mail

emanuele.barbato@olvz-aalst.be